Skip to main content

and
  1. No Access

    Article

    Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia

    B Bilori, S Thota, M J Clemente, B Patel, A Jerez, M Afable II, J P Maciejewski in Leukemia (2015)

  2. Article

    Open Access

    Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia

    An increasing numbers of patients are being diagnosed with asymptomatic early-stage chronic lymphocytic leukemia (CLL), with no treatment indication at baseline. We applied a high-throughput deep-targeted anal...

    A M Hurtado, T-H Chen-Liang, B Przychodzen, C Hamedi in Blood Cancer Journal (2015)

  3. Article

    Open Access

    The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes

    Nonsynonymous TP53 exon 4 single-nucleotide polymorphism (SNP), R72P, is linked to cancer and mutagen susceptibility. R72P associations with specific cancer risk, particularly hematological malignancies, have bee...

    K L McGraw, L M Zhang, D E Rollison, A A Basiorka, W Fulp, B Rawal in Blood Cancer Journal (2015)

  4. No Access

    Article

    Recurrent genetic defects on chromosome 7q in myeloid neoplasms

    N Hosono, H Makishima, A Jerez, K Yoshida, B Przychodzen, S McMahon in Leukemia (2014)

  5. Article

    Open Access

    Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation

    T-cell large granular lymphocytic (T-LGL) leukemia is a clonal disease characterized by the expansion of mature CD3+CD8+ cytotoxic T cells. It is often associated with autoimmune disorders and immune-mediated ...

    E I Andersson, H L M Rajala, S Eldfors, P Ellonen, T Olson, A Jerez in Blood Cancer Journal (2013)

  6. No Access

    Article

    Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies

    I Gómez-Seguí, H Makishima, A Jerez, K Yoshida, B Przychodzen, S Miyano in Leukemia (2013)

  7. No Access

    Article

    SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts

    V Visconte, H Makishima, A Jankowska, H Szpurka, F Traina, A Jerez, C O'Keefe in Leukemia (2012)

  8. No Access

    Article

    Measuring the prognostic impact of ferritin levels in myelodysplastic syndrome patients: the role of susceptibility biases

    A Jerez, A Fernández, M M Osma, V Roldán, F J Ortuño, V Vicente in Leukemia (2010)